ZimVie Inc. is poised to conclude its tenure as a publicly traded entity after shareholders formally approved its acquisition by private equity firm ARCHIMED. The transaction, scheduled for completion on October 20, has now cleared its final significant obstacle.
Investors will receive $19.00 per common share in cash, representing a substantial premium of approximately 99% over the stock’s 90-day average trading price prior to the acquisition announcement. This values the entire company at around $730 million.
Exceptional Returns for Equity Holders
The $19.00 per share purchase price notably exceeds the average analyst price target of $17.75. Market observers had maintained a cautious stance toward the stock, with five analysts most recently issuing “reduce” recommendations. ARCHIMED’s offer, however, delivers an unexpectedly favorable outcome for shareholders.
Following the transaction’s finalization, ZimVie shares will be delisted from the Nasdaq Global Select Market, marking the company’s transition to private ownership.
Should investors sell immediately? Or is it worth buying ZimVie?
Strategic Transformation Culminates in Buyout
This acquisition represents the culmination of an extended strategic repositioning for the company. Earlier this year, in April 2024, ZimVie divested its spine business to H.I.G. Capital for $375 million, subsequently focusing exclusively on its dental implant operations.
Recent corporate activities had signaled the impending takeover. The company withdrew its annual guidance in July and canceled its earnings presentation. Their most recent quarterly report disclosed revenue of $116.7 million and adjusted earnings per share of $0.26.
Final Steps Toward Completion
With shareholder approval secured, only standard closing conditions remain before the October 20 finalization. For investors, this means they will receive their cash consideration within days while bidding farewell to ZimVie as a publicly traded security.
Ad
ZimVie Stock: Buy or Sell?! New ZimVie Analysis from January 20 delivers the answer:
The latest ZimVie figures speak for themselves: Urgent action needed for ZimVie investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 20.
ZimVie: Buy or sell? Read more here...
